Squarepoint’s Ambrx Biopharma Inc AMAM Stock Holding History

Squarepoint’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15,470	Closed	-$220K	–	4779
2023 Q4	$220K	Sell	15,470 -6,662	-30%	-$75.7K	﹤0.01%	3534
2023 Q3	$255K	Buy	22,132 +5,652	+34%	+$77K	﹤0.01%	3275
2023 Q2	$271K	Sell	16,480 -1,031	-6%	-$13K	﹤0.01%	3027
2023 Q1	$156K	Buy	+17,511	New	+$88K	﹤0.01%	2875

Squarepoint's AMAM Position: Q1 2024 in Review

Squarepoint sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 15,470 shares — an estimated $220K sold.

Squarepoint first reported a position in AMAM in Q1 2023 and held it in 4 quarters. The position peaked at $271K in Q2 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Squarepoint reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Squarepoint sold 15,470 Ambrx Biopharma Inc shares in Q1 2024, an estimated $220K.
Squarepoint first reported a position in Ambrx Biopharma Inc in Q1 2023 and held it in 4 quarters.
Squarepoint's Ambrx Biopharma Inc position peaked at $271K in Q2 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Squarepoint's 13F filing for Q1 2024, filed 15 May 2024.